InfraTrac, founded with a mission to combat counterfeiting, leverages near-infrared (NIR) spectroscopy to ensure the authenticity of high-value substances such as pharmaceuticals, chemicals, and consumer products. The company offers two primary products: detector software that provides a straightforward yes-no counterfeit detection interface and encryption software that allows for the tagging of substances at the batch level using a covert NIR fingerprint. InfraTrac's market focus includes industries where product integrity is critical, such as healthcare and manufacturing.

Notable figures associated with InfraTrac include Dr. Sharon Flank, a key innovator in the field of anti-counterfeiting technology. The company's achievements include the development of patent-pending technologies that enhance product verification and quality assurance, particularly in 3D printing. InfraTrac's impact is significant in protecting patients and consumers by ensuring the authenticity of products, thereby reducing the risks associated with counterfeit goods.